False-positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography imaging caused by retained gauze in a woman with recurrent ovarian cancer: A case report

European Journal of Gynaecological Oncology

Volumn 26, Issue 4, 2005, Pages 451-453

  Chen, M Y ^a   Ng, K K ^a   Ma, S Y ^a   Wu, T I ^a   Chang, T C ^a   Lai, C H ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

False positive; Gauze; Ovarian neoplasms; PET

Indexed keywords

CA 125 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BANDAGES AND DRESSINGS; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; GAUZE; GRANULOMATOSIS; HUMAN; INFLAMMATION; LIVER METASTASIS; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY;

ADENOCARCINOMA, PAPILLARY; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOREIGN-BODY REACTION; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SURGICAL PROCEDURES, OPERATIVE; SURGICAL SPONGES;

EID: 23744503939     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Berek J.S.: "Epithelial ovarian cancer". In: "Practical Gynecologic Oncology". Berek J.S., Hacker N.F. (eds.) 3rd edition, Philadelphia, Lippincott Williams & Wilkins, 2000, 504.
2. Niloff J.M., Knapp R.C., Lavin P.T., Malkasian G.D., Berek J.S., Mortel R. et al.: "The CA125 assay as a predictor of clinical recurrence in epithelial ovarian cancer". Am. J. Obstet. Gynecol., 1986, 155, 56.
3. Rubin S.C., Hoskins W.J., Hakes T.B., Markman M., Reichman B.S., Chapman D. et al.: "Serum CA125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer". Am. J. Obstet. Gynecol., 1989, 160, 667.
4. Rustin G.J.S., Marples M., Nelstrop A.E., Mahmoudi M., Meyer T.: "Use of CA125 to define progression of ovarian cancer in patients with persistently elevated levels". J. Clin. Oncol., 2001, 19, 4054.
5. Clarke-Pearson D.L., Bandy L.C., Dudzinski M., Heatson D., Creasman W.T.: "Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings. JAMA, 1986, 255, 627.
6. Silverman P.M., Osborne M., Dunnick N.R., Bandy L.C.: "CT prior to second-look operation in ovarian cancer". Am. J. Roentgenol., 1988, 150, 829.
7. Prayer L., Kainz C., Kramer J., Stiglbauer R., Schurawitzki H., Baldt M. et al.: "CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer". J. Comput. Assist. Tomogr., 1993, 17, 626.
8. Funt S.A., Hricak H., Abu-Rustum N., Mazumdar M., Felderman H., Chi D.S.: "Role of CT in the management of recurrent ovarian cancer". Am. J. Roentgenol., 2004, 182, 393.
9. Nakamoto Y., Saga T., Ishimori T., Mamede M., Togashi K., Higuchi T. et al.: "Clinical value of positron emission tomography with FDG for recurrent ovarian cancer". Am. J. Radiol., 2001, 176, 1449.
10. Torizuka T., Nobezawa S., Kanno T., Futatsubashi M., Yoshikawa E., Okada H. et al.: "Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose". Eur. J. Nuclear Med. Mol. Imaging, 2002, 29, 797.
11. Bristow R.E., Carmen M.G., Pannu H.K., Cohade C., Zahurak M.L., Fishman E.K. et al.: "Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT". Gynecol. Oncol., 2003, 90, 519.
12. Lai C.H., Huang K.G., See L.C., Yen T.C., Ma S.Y., Tsai C.S. et al.: "Restaging of recurrent cervical cancer with dual-phase positron emission tomography". Cancer, 2004, 100, 544.
13. Munkarah A., Levenback C., Wolf JK., Bodurka-Bevers D., Tortolero-Luna G., Morris R.T. et al.: "Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer". Gynecol. Oncol., 2001, 81, 237.
14. Tay E.H., Grant P.T., Gebski V., Hacker N.F.: "Secondary cytoreductive surgery for recurrent ovarian cancer". Obstet. Gynecol., 2002, 99, 1008.
15. 18F]fluoro-2-deoxy-D-glucose in oncology". J. Cancer Res. Clin. Oncol., 2000, 126, 560.
16. Kubota R., Kubota K., Yamada S., Tada M., Ido T., Tamahashi N.: "Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose". J. Nucl. Med., 1994, 35, 104.
17. Strauss L.G.: "Fluorine-18 deoxyglucose and false positive results: A major problem in the diagnostics of oncological patients". Eur. J. Nucl. Med., 1996, 23, 1409.
18. Yamada S., Kubota K., Kubota R., Ido T., Tamahashi N.: "High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue". J. Nucl. Med., 1995, 36, 1301.
19. Yen R.F., Chen M.L., Liu F.Y., Ko Y.L., Chieng P.U., Su C.T.: "False-positive 2[F-18]-fluoro-2-deoy-D-glucose positron emission tomography study for evaluation of focal pulmonary abnormalities". J. Formos. Med. Assoc., 1998, 97, 642.
20. Knight S.B., Delbeke D., Stewart J.R., Sandier M.P.: "Evaluation of pulmonary lesions with FDG-PET". Chest, 1996, 109, 982.
21. Sakamoto H., Nakai Y., Ohashi Y., Okamura T., Ochi H.: "Positron emission tomographic imaging of head and neck lesions". Eur. Arch. Otorhinolaryngol., 1997, 254 (suppl. 1), S123.
22. Stokkel M.P., Bongers V., Hordijk G.J., van Rijk P.P.: "FDG positron emission tomography in head and neck cancer: pitfall or pathology?". Clin. Nucl. Med., 1999, 24, 950.
23. Lorenzen J., de Wit M., Buchert R., Igel B., Bohuslavizki K.H.: "Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy". Nuklearmedizin, 1999, 38, 333.